BIB icon

ProShares Ultra NASDAQ Biotechnology

37 hedge funds and large institutions have $16M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

71% less capital invested

Capital invested by funds: $54.6M → $16M (-$38.7M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.3M
Puts
$3.75M
Net Calls
Net Calls Change

Top Buyers

1 +$2.36M
2 +$1.23M
3 +$596K
4
HF
HRT Financial
New York
+$536K
5
Jane Street
Jane Street
New York
+$518K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.3M
2
$2.59M
3
$1.81M
4
$1.54M
5
$1.14M
6
$872K
7
$810K
8
$596K
9
$536K
10
$518K
11
$476K
12
$372K
13
$324K
14
$243K
15
$241K
16
$111K
17
$110K
18
$107K
19
$41K
20
$40K
21
$24K
22
$22K
23
$22K
24
$19K
25
$16K